ResMed (NYSE-Listed RMD) celebrates its 20th Anniversary as a company and its 10th anniversary of listing on the NYSE. In honor of the occasion, Peter C. Farrell, Executive Chairman of the Board and Kieran T. Gallahue, President and CEO ring The Closing BellSM.
|
|
|
You can also download this bell to your desktop:
1. Right-click on the download link
2. Select "Save Target As"
3. Select download location and save.
|
ResMed
ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.
|
